More than 450,000 Australians are estimated to be living with dementia. @healthgovau provides a range of support programs and services for people living with dementia and those who care for them. Read more 💻 https://t.co/3xc8YbWnhn
A proud sponsor of #ADRF2026, @healthgovau is investing through the Medical Research Future Fund to support dementia research. Learn more about research supported under the Dementia, Ageing and Aged Care Mission:
💻 https://t.co/Fjv5Kvpz6W
#dementiaresearch
@healthgovau is investing through the Medical Research Future Fund to support dementia research. Learn more about research supported under the Dementia, Ageing and Aged Care Mission:
💻 https://t.co/Fjv5Kvpz6W
ADNeT is proud to recognise Prof James Vickers with this year's lifetime achievement award
Through his leadership of Wicking Dementia Research & Education Centre at the University of Tasmania he has been a strong research leader and powerful advocate for people with dementia
Associate Professor Paul Yates from Austin Health presenting to #ADRF2026 the latest positive results in the treatment of Alzheimer's disease with new disease modifying therapies
Further information on these treatments can be found at https://t.co/rTN3Y9IJ1i
"We need to join forces between the delirium and dementia world"
Dr Amy Montgomery from University of Technology Sydney speaking in the Australasian Delirium Association 'Delirium and Dementia' Symposium at #ADRF2026
Professor Jane Alty from University of Tasmania on the potential of digital technology in dementia diagnosis and treatment
A powerful reflection on her own clinical research career and important role her grandfather's experience played in her journey
#ADRF2026
The wonderful St Luke's Care Memory Lane Choir bringing the joy to #ADRF2026
You learn more about the choir's wonderful work here
https://t.co/RWv2O8KNUj
Professor Perminder Sachdev, Co-Director of UNSW Centre for Healthy Brain Ageing (CHeBA), delivers our first keynote address... a fascinating reflection on the history and latest innovation in vascular dementia treatment and diagnosis #ADRF2026
And we're off and running with #ADRF2026
Our 2026 Convenor Associate Professor Stephanie Ward officially launches this year's Australian Dementia Research Forum
Starting tomorrow! We're so excited to be in Sydney for #ADRF2026
Look forward to seeing you call for three days of collaboration and discussion at Australia's leading #Dementia research conference
@healthgovau is a Platinum Sponsor for the Australian Dementia Research Forum 2026. The department invests in a range of programs and initiatives including dementia research, support and workforce training programs. Read more 💻 https://t.co/3xc8YbWnhn
Read the latest news and updates on the Australian Dementia Research Forum, which is just a couple of week away! We are pleased to share the release of our detailed agenda. Find out more: https://t.co/k8RTuw9tMh
#ADRF2026#dementia#research
ADNeT Director Professor Chris Rowe on our concerns with Cochrane review of anti-amyloid therapies
"These new anti-amyloid therapies are the most significant breakthrough in decades for the treatment of Alzheimer’s." 1/4
"Over time new drugs were added resulting in much greater long-term benefits. This is where the treatment of AD now sits. Current research and trials will develop drugs that add to the benefit from anti-amyloid treatments. " 3/4